West Pharmaceutical Services (FRA:WPS) Net Income From Continuing Operations : €526 Mil (TTM As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is West Pharmaceutical Services Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. West Pharmaceutical Services's net income from continuing operations for the three months ended in Mar. 2024 was €106 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was €526 Mil.

West Pharmaceutical Services Net Income From Continuing Operations Historical Data

The historical data trend for West Pharmaceutical Services's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

West Pharmaceutical Services Net Income From Continuing Operations Chart

West Pharmaceutical Services Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

Get a 7-Day Free Trial

217.53

284.58

585.69

553.09

544.15

West Pharmaceutical Services Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income From Continuing Operations	Get a 7-Day Free Trial															130.76	143.16	151.14	125.63	106.08

West Pharmaceutical Services Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €526 Mil.

West Pharmaceutical Services (FRA:WPS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (FRA:WPS) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

WST:USA WPS:Germany

Address

530 Herman O. West Drive, Exton, PA, USA, 19341-0645

Website

https://www.westpharma.com

West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.